1. Home
  2. ABEO vs PDLB Comparison

ABEO vs PDLB Comparison

Compare ABEO & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • PDLB
  • Stock Information
  • Founded
  • ABEO 1974
  • PDLB 1960
  • Country
  • ABEO United States
  • PDLB United States
  • Employees
  • ABEO N/A
  • PDLB N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • PDLB
  • Sector
  • ABEO Health Care
  • PDLB
  • Exchange
  • ABEO Nasdaq
  • PDLB Nasdaq
  • Market Cap
  • ABEO 350.2M
  • PDLB 328.3M
  • IPO Year
  • ABEO 1980
  • PDLB 2017
  • Fundamental
  • Price
  • ABEO $6.88
  • PDLB $14.98
  • Analyst Decision
  • ABEO Strong Buy
  • PDLB
  • Analyst Count
  • ABEO 6
  • PDLB 0
  • Target Price
  • ABEO $18.17
  • PDLB N/A
  • AVG Volume (30 Days)
  • ABEO 687.8K
  • PDLB 32.3K
  • Earning Date
  • ABEO 08-14-2025
  • PDLB 10-29-2025
  • Dividend Yield
  • ABEO N/A
  • PDLB N/A
  • EPS Growth
  • ABEO N/A
  • PDLB 83.78
  • EPS
  • ABEO 0.99
  • PDLB 0.71
  • Revenue
  • ABEO $400,000.00
  • PDLB $90,513,000.00
  • Revenue This Year
  • ABEO N/A
  • PDLB $10.97
  • Revenue Next Year
  • ABEO $339.63
  • PDLB $8.59
  • P/E Ratio
  • ABEO $7.02
  • PDLB $20.90
  • Revenue Growth
  • ABEO N/A
  • PDLB 15.50
  • 52 Week Low
  • ABEO $3.93
  • PDLB $10.74
  • 52 Week High
  • ABEO $7.54
  • PDLB $15.06
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 56.13
  • PDLB 61.73
  • Support Level
  • ABEO $6.74
  • PDLB $14.76
  • Resistance Level
  • ABEO $7.05
  • PDLB $14.99
  • Average True Range (ATR)
  • ABEO 0.26
  • PDLB 0.27
  • MACD
  • ABEO -0.03
  • PDLB 0.01
  • Stochastic Oscillator
  • ABEO 30.95
  • PDLB 91.26

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

Share on Social Networks: